About Us


Genome Explorations International is a premier research organization with the mission to provide global genomic profiling and molecular diagnostics. The Company serves academic centers, the pharmaceutical industry, oncologists, and pathologist with innovative diagnostic, prognostic, predictive, and personalized testing. In conjunction with providing these services, the Company is using the accumulated data, and ongoing clinical information to develop innovative predictive Assays that can provide clinical and diagnostic treatment information and protocols for the medical community.

Clinical Testing Laboratory



Each member of our leadership team brings over 25 years of experience in various types of healthcare — including in laboratories, hospitals, long-term care facilities and physician practices — allowing them to meet specialized needs and concerns. Meanwhile, our labs’ clinicians, scientists, pathologists, engineers and technicians are uniquely skilled in developing customized next-generation sequencing (NGS) panels. Meet our leadership team.



We work closely with leaders across healthcare — including in hospitals, physician practices, the National Institutes of Health and governmental research entities — to help drive new advances in diagnostics, treatments, pharmaceuticals, medical devices and research. Learn about our partners.



With advanced R&D capabilities and a proprietary mapping process, we can build NGS panels that are tailored to client needs and provide a foundation for predictive outcomes regarding the most common chronic health conditions. Learn about our technology.


Genome Explorations International collaborates with organizations across the healthcare continuum to address the most important challenges they face today, including:

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Enhancing treatment plans for patients with chronic conditions

Working Together to Advance Patient Care, Genome Explorations International focuses on high-complexity testing and works closely with leading healthcare organizations to improve management of and outcomes for patients with chronic diseases.

Developing new drugs and medical devices

By leveraging our genetically integrated medical platform, utilized by our network of state-of-the-art genetic labs, we help our partners achieve key strategic goals and transformational results.

Our experienced team is skilled in creating next-generation sequencing panels to identify changes in chromosomes, genes or proteins. Based on our partners’ objectives, we customize these panels along with our workflows to better identify predictors of specific diseases.

Expanding access to and application of genetically targeted data

Our internal processing of bioinformatics allows us to analyze hundreds of thousands of potential genetic combinations to better discern patterns and connectivity. We can accomplish this feat — which previously was difficult, if not impossible, to achieve — thanks to our expansive and comprehensive genetic database. Our groundbreaking analytics approaches to targeted genetic sequencing and unrelenting commitment to quality and compliance have proven Genome Explorations International is a leader in providing solutions to the medical industry.


The information below gives insight to just a few of the benefits that Genome Explorations International provides our employees in our various departments ranging from corporate services, clinical services, and pharma services:


  • Competitive base salaries
  • Paid vacation and holiday time
  • Short and long-term disability
  • Competitive health benefits
  • 401(k) investment plans
  • Training and development opportunities
  • Community outreach opportunities


Sapio Sciences was established in May of 2004. The etymological root of their company name, Sapio, is Latin and can be roughly translated into English as “to know” or “to grasp”. They selected it because their products and technologies are designed to help scientists, researchers and physicians at leading pharmaceutical, biotech and non-profit organizations gain enhanced knowledge about their biological samples, lab procedures, clinical trials, analytics results and biological data. They believe that knowledge created through the implementation of our technologies will be broadly used to improve the quality of work in laboratories and will facilitate discoveries by researchers to improve the quality of life.

Southern Research Institute is a diversified network of collaborative centers for scientific discovery and technology development. They’re a recognized leader in leveraging more than 60 years of achievement to create innovative solutions for public and private sector clients in the pharmaceutical sciences, automotive, engineering, and environment and energy industries. Learn more about Southern Research by visiting their website.


Charles River Laboratories’ 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Their leading-edge products and services enable their clients to bring drugs to market faster and more efficiently. Backed by their rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, Charles River Laboratories Research Models and Preclinical Services including Phase I Clinical Services, are unequaled in the drug development business.

Learn more about Charles River by visiting their website.

Stratagene is a worldwide leader in developing innovative products and technologies for life science research. They support advances in science by inventing, manufacturing, and marketing products that simplify, accelerate, and improve research. Since 1984, their products have been used throughout the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.

Through the strategic alliance with Stratagene, Genome Explorations offers the latest in data analysis solutions.